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Background: The integrated stress response (ISR) is necessary to help the tumor adapt to its microenvironment.
Results: ATF4 activates a PEPCK-M-dependent pro-survival pathway under amino acid deprivation or ER stress (ISR) by
binding to its proximal promoter.
Conclusion: PEPCK-M participates in supportive adaptations of cancer cells under stress.
Significance: A previously unappreciated role for PEPCK-M in cancer cells opens a therapeutic window and enhances our
understanding of cancer metabolism.
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M),
encoded by the nuclear PCK2 gene, links TCA cycle intermedi-
ates and glycolytic pools through the conversion of mitochon-
drial oxaloacetate into phosphoenolpyruvate. In the liver
PEPCK-M adjoins its profusely studied cytosolic isoform
(PEPCK-C) potentiating gluconeogenesis and TCA flux. How-
ever, PEPCK-M is present in a variety of non-gluconeogenic tis-
sues, including tumors of several origins. Despite its potential
relevance to cancer metabolism, the mechanisms responsible
for PCK2 gene regulation have not been elucidated. The present
study demonstrates PEPCK-M overexpression in tumorigenic
cells aswell as themechanism for themodulationofPCK2abun-
dance under several stress conditions. Amino acid limitation
and ER stress inducers, conditions that activate the amino acid
response (AAR) and the unfolded protein response (UPR), stim-
ulate PCK2 gene transcription. Both the AAR and UPR lead to
increased synthesis of ATF4, which mediates PCK2 transcrip-
tional up-regulation through its binding to a putative ATF/CRE
composite site within the PCK2 promoter functioning as an
amino acid response element. In addition, activation of the
GCN2-eIF2-ATF4 andPERK-eIF2-ATF4 signaling pathways
are responsible for increased PEPCK-M levels. Finally,
PEPCK-M knockdown using either siRNA or shRNA were suf-
ficient to reduce MCF7 mammary carcinoma cell growth and
increase cell death under glutamine deprivation or ER stress
conditions. Our data demonstrate that this enzyme has a critical
role in the survival program initiated upon stress and shed light
on an unexpected and important role of mitochondrial PEPCK
in cancer metabolism.
Phosphoenolpyruvate carboxykinase (PEPCK)4 (GTP; EC
4.1.1.32) activity, which catalyzes the conversion of oxaloace-
tate to phosphoenolpyruvate (PEP), is distributed both in the
cytosol andmitochondria as a result of two enzymatically indis-
tinct isozymes, PEPCK-C and PEPCK-M (1, 2), encoded by
different nuclear genes (Pck1 and Pck2, respectively) (3).
PEPCK-C, the first committed step of gluconeogenesis and
glyceroneogenesis, is restricted to differentiated liver, small
intestine, kidney cortex, and adipose tissue, whereas PEPCK-M
appears not to be constrained to those tissues as it is expressed
in a variety of cell types, including T- and B-cells, pancreatic
-cells, or neurons. It is important to note that the PEPCK
reaction is the only pathway that is able to communicate mito-
chondrial intermediates with the glycolytic intermediary pool
above PEP. Although the role of the mitochondrial isozyme
remains largely unknown, recent reports have shown a complex
interactionwith its cytosolic counterpart toward hepatic gluco-
neogenesis through cataplerosis of mitochondrial precursors
(4). In pancreas, PEPCK-M was highly expressed in -cells
where it enhanced TCA cycle dynamics via its recycling of GTP
generated at the succinyl-CoA synthase reaction (5). Thus,
PEPCK-M activity pumped the TCA cycle and sourced PEP
toward pyruvate formation to feed acetyl-CoA for the citrate
synthase reaction (pyruvate cycling), altogether regulating glu-
cose-stimulated insulin secretion. Interestingly, and in contrast
to its cytosolic counterpart, hormones or nutrients that are
known to regulate gluconeogenesis do not transcriptionally
regulate the gene coding for PEPCK-M, PCK2.
Eukaryotes have evolved complex mechanisms to allow cells
to confront and adapt to variable conditions such as nutrient
limitations. One such process, known as integrated stress
response (ISR), collectively groups several signaling pathways
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that converged on the phosphorylation of eIF2 and comprise
responses triggered by amino acid starvation (amino acid
response (AAR)) or endoplasmic reticulum stress (unfolded
protein response (UPR)) leading to the activation of target
genes. The interplay of downstream activating pathways with
the severity and duration of stress determines the fate of the
cell, thus ensuring cell viability or activation of cell death.
Importantly, tumors dynamically activate ISR to allow cancer
cells to cope with metabolic limitations.
In the present work we describe the selective expression of
PCK2 in several human tumors and all cancer cell lines studied,
suggesting that PEPCK-M activity might support specific pur-
poses in the context of tumor metabolic adaptations. Expres-
sion is sensitive to several cues that signal through the canonical
ISR response, including chemical inducers of UPR and amino
acid limitations. The mechanism of PCK2 gene regulation in
cancer cells under ISR requires recruiting ATF4 to a consensus
amino acid response element (AARE) sequence located in the
PEPCK-M proximal promoter. Finally, we provide evidence on
the importance of this gene as a pro-survival mechanism under
conditions of stress, probably by channeling TCA intermedi-
ates into the triose-phosphate pool. Hence, PEPCK-M up-reg-
ulation is a novel metabolic adaptation in cancer.
EXPERIMENTAL PROCEDURES
Cell Culture—Human breast (MCF7), cervix (HeLa), and
colon (HCT116) carcinoma cell lines andmousewild typeNIH-
3T3 and Kras-V12 carcinogenic NIH-3T3 (NIH-3T3Kras) (a
gift from Dr. Capella, The Bellvitge Institute for Biomedical
Research (IDIBELL), Spain) and PKR-like endoplasmic reticu-
lum-resident kinase (PERK)-deficient mouse embryonic fibro-
blasts (a gift from Dr. Douglas R. Cavener, Pennsylvania State
University) were maintained in DMEM supplemented with
10% FBS, 10000 units/ml penicillin, 10 mg/ml streptomycin,
and 2mML-glutamine (Biological Industries) and incubated in a
humidified atmosphere of 5%CO2 at 37 °C. Thapsigargin, tuni-
camycin, actinomycin D, and etoposide were purchased from
Sigma.
RNA Extraction and Quantitative RT-PCR—Total RNA was
extracted using UltraspecTM RNA isolation system (Biotecx,
TX). cDNA synthesis from 2 g of RNAwas performed using a
High Capacity cDNA Reverse Transcription kit (Invitrogen).
cDNA was analyzed using real-time quantitative RT-PCR
assays in a 7900HT real-time RT-PCR system (Applied Biosys-
tems, Carlsbad, CA). Data analysis is based on the Ct
method.
Western Blot—Cells were homogenized in radioimmunopre-
cipitation assay buffer supplemented with protease and phos-
phatase inhibitors and centrifuged at 15,000  g for 15 min at
4 °C. Western blots were performed with 20–50 g of tissue
extract. Proteins were separated in 8–12% SDS-PAGE and
transferred to an Immobilon membrane (Millipore, Bedford,
CA). Horseradish peroxidase activity linked to secondary anti-
bodywas detectedwith ECL substrate (Pierce) in a FujifilmLAS
3000 Intelligent Dark Box IV imaging system. Antibodies used
to detect PEPCK-M were rabbit anti-PEPCK-M (Abcam;
ab70359) and goat anti-PEPCK-M (Fig. 1A) (Everest Biotech;
EB06944). Antibodies against ATF4, GCN2 (general control
nonderepressible 2), C/EBPC/EBP, and-actininwere from
Santa Cruz. -Tubulin and -tubulin antibodies were pur-
chased from Sigma. Phospho-specific antibody against eIF2
(Ser-51) was fromCalbiochem. Anti-SOD1was fromNovocas-
tra. Anti-SOD2 was from Stressgen. Anti-co-chaperone p23
was from Affinity Bioreagents. Anti-green fluorescent protein
(GFP) was from Abcam. Antibodies detecting total eIF2,
VDAC (voltage-dependent anion channel protein), caspase-7,
and PARP (poly(ADP-ribose) polymerase) were from Cell Sig-
naling. Antibodies against cytosolic PEPCK were a generous
gift of Dr. Daryl K. Granner (Vanderbilt University, Nashville,
TN).
Histology and Immunofluorescence—PEPCK-M was immu-
nostained as previously described (4). For mitochondrial label-
ing, cultured cells were incubated in culturemedia containing a
0.1M final concentration ofMitoTracker RedCMXRos (Invit-
rogen) dissolved in dimethyl sulfoxide for 20 min in a 37 °C, 5%
CO2 gas incubator. The cells were washed with PBS and fixed
with 4% paraformaldehyde in PBS for 10 min and permeabi-
lized by incubating with 0.2% Triton X-100 in PBS for 10 min.
Cells were then blocked by incubating with 3% BSA in PBS for
30 min and treated with the PEPCK-M primary antibody
(ab70359; Abcam) for 16 h. After 4 washes with 0.1% Triton in
PBS, cells were incubated with anti-rabbit Alexa Fluor 488
secondary antibody ((Invitrogen) for 1 h and during this incu-
bation TO-PRO3 was added to stain nuclei. Samples were
examined using a confocal microscope (TCS SL, Leica), and
LCS Lite software (Leica) was used to collect digital images.
Subcellular Fractionation—Cells were incubatedwith digito-
nin (50 g/ml) for 4 min on ice and centrifuged at 1200 g for
10min to remove large cell and tissue fragments and cell nuclei.
Pellet 1 was discarded, and mitochondria were pelleted by cen-
trifuging the supernatant at 12,000 g for 10 min. Cytosol was
mixed with 4 SDS sample buffer (0.250 M Tris, pH 6.8, 8%
SDS, 40% glycerol, 4% -mercaptoethanol, 0.04% bromphenol
blue). Pellet-containing mitochondria were resuspended in the
same SDS buffer (25 mM Tris-HCl, 1 mM EDTA, 1 mM EGTA,
1% SDS, pH 7.4) andmixedwith 4 SDS sample buffer to reach
total final volume equal to cytosol. Western blots were per-
formedwith equal volumes of cytosolic andmitochondrial frac-
tions tomaintain a correct correlation relative to freshmaterial.
Proteins were separated in 12% SDS-PAGE.
Plasmid Constructs—The PCK2 promoter region was ampli-
fied from human genomic DNA and cloned into the luciferase
reporter vector PGL3-basic (Promega, Mannheim, Germany).
The three sequences of the recombinant plasmids, PCK2–
1825/42, PCK2–808/42, and PCK2–214/42, were ampli-
fied and subcloned independently using an initial amplification
product as template (5-CTCAGCAGCTCCAGGCTTAT-
ATTC and 5-CATGCCAGTTAAGCCGCAGGCCAG) and
introducing SacI and HindIII restriction sites in the PCR prim-
ers (SacI-1-fw, 5-ACTCAGCAGAAAGAGAGCTCACT-
TCC-3; SacI-2-fw, 5-GCAGGCGGATCACGAGCTCAGG-
AGT-3; SacI-3-fw, 5-TGTGCGGCTGGGAGCTCGGTGG-
CGGATGGG-3; HindIII-rev, 5-GAGCGCGGCGAAGCT-
TGCCACAGCAGAGGC-3). Point mutations in the AARE
sequences were introduced by PCR. The primer sequences
were as follows (the AAREs are underlined, and the mutated
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nucleotides are shown in bold in the forward sequences):
AARE1-fw, 5-AGTCCTCAAAGGCATAGTATGTGCGG-
CTG-3; AARE1-rev, 5-CAGCCGCACATACTATGCCTTT-
GAGGACT-3; AARE2-fw, 5-GGGCAGATGAGGCTACT-
TATTGGATTGTG-3; AARE2-rev, 5-CACAATCCAATAA-
GTAGCCTCATCTGCCC-3.
Transfection and Luciferase Assays—Cell transfection was
performed using polyethyleneimine (linear polyethyleneimine,
Mr 25,000, Sigma). The different promoter plasmids (2 g) and
0.25 g of pSV40--galactosidase control vector (Promega)
were co-transfected into 6-well plates containing 80% conflu-
ent cells and then distributed into 24-well plates. Cells were
maintained overnight in complete medium and treated as indi-
cated. Luciferase activity was measured in a TD 20/20 lumi-
nometer (Turner Designs) using the Luciferase Assay System
(Promega) as previously described (6). In overexpression exper-
iments, the transcription factor expression plasmids (100 ng of
each) were co-transfected with the promoter constructs, and
luciferase activity was measured 24 h after transfection. The
total amount of transfectedDNAwas kept constant by the addi-
tion of empty pcDNA3.1 plasmid. The luciferase values were
normalized to protein content and to -galactosidase activity
using the luminescent -galactosidase detection kit II (Clon-
tech). C/EBP (CCAAT/enhancer-binding protein) vectors
were a gift of Richard W. Hanson (Case Western Reserve Uni-
versity, Cleveland, Ohio). ATF4 and ATF3 cDNA vectors were
gifts of Diego Haro (Universitat de Barcelona, Barcelona,
Spain).
Chromatin Immunoprecipitation (ChIP)—ChIP assays were
performed as described previously (6). Briefly, chromatin from
treatedMCF7 cells was sonicated to an average fragment size of
400–500 bp in a Branson Sonifier (8 cycles of 10 s sonication
with a 30-s rest time at 4 °C). Rabbit or mouse IgG (Sigma) was
used as a control for nonspecific interaction of DNA. Input was
preparedwith 10%of the chromatinmaterial used for an immu-
noprecipitation. Later, a 1:10 dilution of inputmaterial was per-
formed before PCR amplification. PCR products were resolved
in agarose gel. Densitometry was performed usingMulti Gauge
software. Primers sequences were: PCK2-AARE1, 5-CTCGT-
TCCTAGCTTGTTTGCCACC-3 and 5- GCCAAACCCAT-
CTCTCCCATTGGA-3; PCK2-AARE2, 5-GTGGGTGATA-
TCCAGTGGTCTCAG-3 and 5-GGCCTGGTCATTCTT-
TCTCTCCA-3; ASNS, 5-TGGTTGGTCCTCGCAGG-
CAT-3 and 5-CGCTTATACCGACCTGGCTCCT-3.
RNA Interference (RNAi)—Small interfering RNA (siRNA)
oligonucleotides targeting human PCK2 (PCK2#1, 5-CAAG-
GAUGUGGCACGAGUATT-3; PCK2#2, 5-GGGCCAUCA-
ACCCUGAGAATT-3; PCK2#3, 5-UGGCUACAAUCCAG-
AGUAATT-3), ATF4 (5-GCCUAGGUCUCUUAGAUG-
ATT-3), GCN2 (5-CAGCAGAAAUCAUGUACGATT-3),
and control non-silencing siRNA (scramble, SCR: (5-UUCU-
CCGAACGUGUCACGUTT-3) were purchased from Shang-
hai GenePharma. MCF7 and HeLa cells were transfected
using Oligofectamine transfection reagent (Invitrogen) as
specified by the manufacturer. Cells were used in experi-
ments 48 h after siRNA transfection. PCK2 was silenced
using a pool of three individual siRNA. For PCK2 knock-
down with shRNA, GIPZ Lentiviral shRNAs (Open Biosys-
tems, clone IDs: V3LMM_427490 and V3LHS_328126,
denominated B and C, respectively) were used. GIPZ non-
silencing lentiviral shRNA (clone ID RHS-4348) was used as
negative control. After transduction, cells were selected with
puromycin and sorted by fluorescein-activated cell sorter
(FACS) based on turboGFP fluorescence.
Glycolytic Rate Measurement—Glycolytic rate was deter-
mined by measuring the conversion of D-[5-3H]glucose to
3H2O, released by the enolase step of glycolysis (7). Briefly, cells
were incubated with 5 Ci of D-[5-3H]glucose (American
Radiolabeled Chemicals, St. Louis, MO) at 37 °C for 60 min.
After incubation, triplicate 50-l aliquots were transferred to
uncapped PCR tubes containing 50 l of 0.2 N HCl, and each
tube was transferred to a scintillation vial containing 0.5 ml of
H2O so that the water in the vial and the contents of PCR tube
were not allowed to mix. The vials were sealed, and the diffu-
sion took place for 24 h. The amount of diffused and undiffused
3H2O was determined by scintillation counting and compared
with controls of D-[5-3H]glucose and 3H2O alone.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bro-
mide (MTT) Proliferation Assay—For the MTT assay, (0.5
mg/ml final concentration) was added to each well, and then
the plates were incubated at 37 °C for 3 h. The formazan prod-
uct was dissolved in isopropyl alcoholHCL, and the absorbance
at 570 nm was measured using a microplate reader.
Analysis of Viability by Phosphatidylserine Exposure andPro-
pidium Iodide Uptake—Cell viability in siRNA-treated MCF7
cells was determined by analyzing phosphatidylserine exposure
and membrane integrity by double staining with annexin
V-FITC and propidium iodide before flow cytometric analysis
(FACSCalibur, BD Biosciences) using the annexin V-FITC
Apoptosis Detection kit (eBioscience, San Diego, CA). Data
analysis was performed with CellQuest software (BD Biosci-
ences). For GFP expressing MCF7-shRNA clones, annexin
V-allophycocyanin, and 7-aminoactinomycin D (eBioscience)
were used and analyzed on FACS Canto (BD Biosciences).
Statistical Analysis—Results are expressed as the means 
S.E. Statistical analysis was performed by one-way ANOVA
(Newman-Keuls post-hoc test) and two-tailed Student’s t test
using GraphPad Prism software. p  0.05 was considered
significant.
RESULTS
PCK2, Not PCK1, Is Present in Tumors and Tumorigenic Cell
Lines—Data mining through curated array data at BioGPS
pointed at tumor-specific expression of PCK2 that correlated
with aggressive growth andwas evident in either tumor-bearing
mice, human tumors, or chemically induced tumors. To con-
firm, we assayed PCK2 mRNA levels in tumor cell lines of
human and compared them to those of the cytosolic isoform
(PCK1; PEPCK-C). Table 1 shows raw Ct expression of both
genes, confirming that PCK2 is highly expressed in all tumori-
genic cell lines tested to date, whereas PCK1 is below the detec-
tion level. However, in immortalized fibroblasts or differenti-
ated C2C12 or NIH3T3-L1 a higher amount of PCK1 mRNA
was observed. Interestingly, Kras-activated NIH-3T3 (NIH-
3T3Kras) cells do not express significant levels of Pck1mRNA,
whereas greatly overexpress Pck2 mRNA in contrast to non-
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tumorigenic parent cell line (NIH-3T3). Protein concentration
was also assayed in three cell lines by subcellular fractionation
(Fig. 1A), confirming that mitochondrial PEPCK (PEPCK-M;
PCK2) was the only PEPCK activity expressed in these cell lines
and was properly localized to the mitochondria. As expected,
no PEPCK-C protein was present in these cell lines (Fig. 1B).
Immunocytochemistry localized PEPCK-M exclusively in the
mitochondria of MCF7 cells (Fig. 1C).
Nutrient Restriction Up-regulates PCK2 Expression—Because
PEPCK-M regulates TCA cycle dynamics and cataplerosis, we
hypothesized that it might also regulate carbon flux during
nutrient stress, as the TCA is key to mobilize intermediates
toward biosynthetic processes. Glutamine represents the quan-
titatively most important TCA cycle fuel in cancer cells; conse-
quently, we investigated whether PCK2 mRNA is regulated by
withdrawal of these amino acids. qRT-PCR analysis confirmed
that PCK2 mRNA content increased at least 2-fold after gluta-
mine deprivation in all cell lines tested (Fig. 1D). PCK2 mRNA
measured inMCF7 andNIH-3T3Kras cell lines at various treat-
ment times (0–8 h) demonstrates a rapid (within 2–4 h) and
robust induction in response to the lack of glutamine (Fig. 1E).
To determine whether this induction could be reproduced by
the withdrawal of other amino acids, MCF7 and HCT116 cells
were incubated for 8 h inmedia lacking a particular amino acid.
qRT-PCR analysis confirmed that PCK2 expression was
induced by the depletion of either single amino acid tested, even
at similar or higher levels of those seen upon glutamine depri-
vation (Fig. 1F). IncreasedmRNA levels correlated with protein
concentration at 24 h after depletion of glutamine or serine and
glycine in MCF7 cells (Fig. 1G).
ER Stress Increases PEPCK-M Content—AARs and ER stress
share a common downstream effector mechanism; inhibition
of translation by phosphorylation of eIF2. Therefore, we
examined the hypothesis that ER stress would also regulate
PCK2 expression. To test this hypothesis, chemical inducers of
ER stress response, thapsigargin (a sarcoendoplasmic Ca2-AT-
Pase inhibitor), or tunicamycin (a glycosyltransferase inhibitor)
were submitted to MCF7 or HeLa cells for 0 to 8 h; DMSO was
added in control wells (vehicle). As seen in Fig. 2, PCK2 levels
were induced up to 3-fold upon thapsigargin or tunicamycin
treatment (Fig. 2,A and B). We next examined the effects of ER
stressors (increasing doses of thapsigargin or tunicamycin for
24 h) on PEPCK-M protein content. A robust dose-dependent
accumulation of PEPCK-Mwas observed inMCF7 cells treated
with tunicamycin (Fig. 2C) and HCT116 treated with both
drugs (data not shown). PCK2 up-regulation was the conse-
quence of direct transcriptional activation downstream of ER
stress signaling as actinomycin-D, a RNA polymerase II inhib-
itor, prevented the accumulation of PCK2mRNAby either glu-
tamine deprivation or thapsigargin (Fig. 2D).
To rule out an indirect effect on PCK2 transcription by stress
conditions other than ER stress, we examined the modulation
of PCK2 mRNA levels by H2O2, an effector of oxidative stress
pathways, and the topoisomerase II inhibitor etoposide, which
triggers DNA damage and stimulates apoptotic response.
Results shown in Fig. 2Fdemonstrate that these stressors donot
modulate PCK2 levels, ruling out an indirect activation of PCK2
transcription by chemical inducers of ER stress. On the other
hand, to assess PCK2 transcription regulation in physiologic
conditions of ER stress, its mRNA content and protein levels
were quantified in MCF7 cells on a low glucose medium. As
observed in Fig. 2, E and F, glucose limitation was also capable
of up-regulating mitochondrial PEPCK in MCF7.
An AARE Consensus Site at the PCK2 Promoter Recruits
ATF4 to Activate Transcription under AAR or ER Stress—Tran-
scriptional up-regulation was responsible for increased
PEPCK-M protein levels observed; therefore, we evaluated
whether a downstream transcriptional effector of ER or amino
acid stress response directlymediated this induction. Promoter
sequences ranging in size from214 to1285 upstream of the
transcriptional start site of the human PCK2 gene were engi-
neered as luciferase reporter constructs as shown in Fig. 3A.
Luciferase activity fromMCF7 cells transiently transfectedwith
these constructs (PCK2/1285, PCK2/808, and PCK2/-214)
was studied under glutamine or serine plus glycine deprivation
or thapsigargin stimulus. Although PCK2/1285 and 808
sustained identical induction by stress stimuli, PCK2/214 had
a blunted response (Fig. 3A). These data suggest that the
sequence from 808 to 214 of the human PCK2 gene pro-
moter may contain a relevant element responsible for the
increase in luciferase activity after treatments. Detailed in silico
analysis of the promoter sequence revealed the presence of dif-
ferent putative consensus binding sites for the ATF (activating
transcription factor) family of transcription factors, referred to
as the C/EBP-ATF composite site and also known as AARE.
AARE sequences bindmonomers and homo- and heterodimers
of ATF and C/EBP proteins, both subfamilies of the larger bZIP
(basic region/leucine zipper) transcription factor family.
The relative contribution of these sites to promoter activity
was then assessed using reporter constructs with specificmuta-
tions at each of the AARE sites (AARE1 and AARE2) found in
the proximal promoter of the PCK2 gene (see “Experimental
Procedures”). Gene reporter assays showed that mutations in
the AARE1 response element severely abrogated response,
both to ER stress induction by thapsigargin and amino acid
limitation (Fig. 3B). In contrast, mutations in the AARE2 bind-
ing element had minor effects on transcriptional activity. The
AARE1 site (GTTACATCA), located at position 917 bp
upstream of the nucleotide designated as1, in the 5-flanking
region of the human PCK2 promoter matches a functional
C/EBP-ATF composite site present in the FGF21 gene pro-
TABLE 1
mRNA abundance of PEPCK isozyme encoding genes in several
human andmouse cell lines
Species Cell line
Raw Ct values
PCK2/Pck2 PCK1/Pck1
Human MCF7 27.4 	35
HeLa 28.7 	35
Jurkat 28.9 	35
Saos 25.6 	35
T98G 26.5 	35
U2OS 25.4 	35
U87 26.5 	35
SH-SY5Y 34.3 	35
Mouse MEF 24.2 	35
C2C12 29.1 32.7
3T3 L1 24.1 32.4
MC-3T3 24.8 33.9
NIH-3T3KrasV12 22.0 	35
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moter that binds ATF4 andC/EBP (8) (Fig. 3C). PCK2AARE1
sequence is highly conserved in mammals (Fig. 3D). Therefore,
it was likely that an ATF-C/EBP family member also binds to
and transactivates, through the PCK2 AARE-1. To determine
whether these proteins affected PCK2 gene transcription, we
studied the transcriptional response of the reporter constructs
upon overexpression of ATF4, ATF3, c/EBP, andC/EBP and
GFP (as control) in MCF7 cells. Fig. 3E shows that ATF4 over-
expression robustly stimulated the transcriptional activity of
the wild type construct containing both AARE1 and AARE2
sites, whereas constructs lacking the AARE1 site remained
unstimulated, suggesting that AARE1may be the site responsi-
ble forATF4-mediated activation. Even though the overexpres-
sion of ATF3 did not produce a significant increase in promoter
activity by itself, its co-expression with ATF4 potentiated tran-
scriptional activity (Fig. 3F). Consistent with these results over-
expression of ATF4, but not ATF3, was sufficient to produce a
robust increase in PEPCK-M levels (Fig. 3, G–I). Overexpres-
sion of either C/EBP or C/EBP also potentiated the ATF4
effect on luciferase activity, whereas both had minor effects
when overexpressed alone (Fig. 3F). Neither c/EBP, C/EBP
(Fig. 3J), LAP (activator), nor LIP (inhibitor) isoforms of
C/EBP independently (Fig. 3K) affected PEPCK-M protein
levels, under basal or stressed conditions. Finally, salubrinal, an
inhibitor of eIF2 dephosphorylation that induces ATF4 pro-
duction, caused a small but significant increase in basal
PEPCK-M protein levels, suggesting that eIF2 activation is
sufficient to initiate the cascade leading to PCK2 up-regulation
(Fig. 3L).
To confirm thatATF4binds to the humanPCK2promoter in
vivo, ChIP assays were performed. Chromatin fragments iso-
lated fromMCF7 cells treatedwith thapsigargin or incubated in
the absence of glutamine for 8 hwere immunoprecipitatedwith
an anti-ATF4 antibody. The immunoprecipitate was tested for
PCK2 promoter sequences by PCR amplification, demonstrat-
ing ATF4 recruitment to the PCK2 promoter region containing
the AARE1 site in vivo (Fig. 3M; quantification provided in Fig.
3N) and supporting the conclusion that ATF4 is the protein
responsible for PCK2 promoter transactivation upon AAR and
UPR induction. As a positive control, ATF4 recruitment in the
AARE site of the asparagine synthase gene was also confirmed
(Fig. 3O).
Both GCN2 and PERK Are Involved in the AAR and UPR-
mediated Induction of PCK2 through ATF4—Conclusively,
knocking downATF4 inMCF7 cells abrogatedATF4 induction
under ER- tress and brought its expression below basal levels in
unstimulated conditions (Fig. 4,A and B). Consequently, ATF4
depletion completely abolished PCK2 induction by thapsi-
gargin and glutamine deprivation and reduced its expression in
unstimulated conditions (Fig. 4, A and B).
FIGURE 1. PEPCK-M is expressed in cancer cells, and its expression is regulated by amino acid limitation. A, PEPCK-M protein expression detection in
different cell lines analyzedbyWesternblot after subcellular fractionation. Cytosolic andmitochondrial superoxidedismutases (SOD1and -2, respectively) and
the mitochondrial voltage-dependent anion channel protein (VDAC) transporter were used as markers. Cyt, cytosol; Mit, mitochondria. B, mitochondrial and
cytosolic PEPCK (PEPCK-M and PEPCK-C, respectively) were measured in the same cell lines shown in A; mouse liver was used as positive control for PEPCK-C,
and Coomassie Bluewas used as the loading control. C, indirect immune detection using confocalmicroscopy of human PEPCK-M endogenously expressed in
MCF7 cells. PEPCK-M staining is shown in green. Mitochondria are visualized using MitoTracker Red CMXRos (red), and nuclei are stained in blue using
TO-PRO3. PEPCK-M andmitochondria colocalize as seen by the yellow in the superimposed image. C–E, quantitative PCRwith human PCK2-specific primers.
D, four different cell lines (see “Experimental Procedures” formore information)were incubatedwithmedia lackingglutamine for 16h. E,MCF7andNIH3T3Kras
cells were glutamine-deprived for the indicated times. F, MCF7 and HCT116 cells were cultured in media lacking glutamine, arginine, lysine, methionine, or
cysteine for 8 h. CT, control. In all cases, the -fold induction of PCK2with respect to basal conditions is represented. Data are presented as themean S.E., n

3–4. *, p 0.05; ***, p 0.001 relative to basal conditions; one-way ANOVA,with a Newman-Keuls post-hoc test.G, PEPCK-Mprotein inductionwas verified by
Western blot in MCF7 cells incubated for 24 h inmedia lacking glutamine, serine and glycine, or arginine as indicated. -Tubulin or -actinin were used as the
loading control.
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We next studied the participation of GCN2 and PERK
kinases involved in the AAR and UPR responses, respectively,
in the events leading to PCK2 up-regulation. GCN2 silencing in
MCF7 blunted PCK2 mRNA up-regulation in response to glu-
tamine deprivation, but not upon thapsigargin treatment (Fig.
4C). This is consistentwith reduced eIF2phosphorylation and
lack of ATF4 induction only under glutamine deprivation con-
ditions (Fig. 4D). Conversely, in PERK knock-out murine
embryonic fibroblasts (Perk/ mouse embryonic fibroblasts)
treated with thapsigargin, PCK2 mRNA levels remained
unchanged (Fig. 4E), consistent with reduced eIF2 phospho-
rylation and blunted ATF4 induction (Fig. 4F). On the other
hand, glutamine deprivation induced a similar increase of
PEPCK-M in both Perk/ and Perk/ cells (Fig. 4E). Taken
together, our results demonstrate that amino acid starvation
and ER stress triggered a cascade of protein kinases including
GCN2, PERK, and eIF2 that mediates ATF4 activation and
subsequent PCK2 up-regulation.
PEPCK-M Is Necessary to Tip the Balance toward Survival
upon AAR and UPR Activation—To investigate the impact of
PEPCK-M knockdown on cell proliferation in basal, unstressed
conditions and under ER stress, we used two strategies: (i) tran-
sient siRNA silencing or (ii) stable shRNAupon lentiviral infec-
tion. Consistently, either strategy reduced PEPCK-M levels sig-
nificantly in exponentially growing MCF7 and HeLa cells that
correlated with a reduction in glucose consumption (Fig. 5A),
lactate production (Fig. 5B) and glycolytic flux (Fig. 5C). Either
PCK2 gene silencing strategy afforded significant negative
effects on cell proliferation (Fig. 5, D and F) without apoptosis
(Fig. 5E), demonstrating that PEPCK-Mhas a significant role in
tumor cells under normal growth conditions.
We next investigated if PCK2 knockdown could decrease the
survival capacity of cells subjected to stress stimuli. For this
purpose, MCF7 cells treated with siRNA against PCK2 were
incubated 24 hwithmedia lacking glutamine or in the presence
of thapsigargin (2 M). Fig. 5, G andH, show that PCK2 silenc-
ing produced a significant increase in caspase 7 activation and
subsequent cleavage of the caspase-dependent PARP and p23
as compared with control siRNA treatment. Flow cytometry
quantitation of apoptotic cells (annexin V-FITC/propidium
iodide staining) (Fig. 5I) showed that late apoptotic cells
(annexin V-FITC positive/propidium iodide positive, upper
right quadrant) in PCK2-silenced cells was statistically
increased (Fig. 5J). Stably infected lentiviral hairpin expression
PCK2 knockdown identically sensitized MCF7 cells to gluta-
mine deprivation and thapsigargin induced death (Fig. 5,K–N).
DISCUSSION
Based on data available in a large number of public databases
and on our own recollection, PEPCK-M expression was in
marked contrast to the absence of its cytosolic counterpart,
PEPCK-C. This suggests that the mitochondrial activity could
FIGURE 2.PEPCK-M is activatedby ER stress.MCF7 andHeLa cells were incubatedwithmedia containing 500 nM thapsigargin (A) or 2M tunicamycin (B) for
the indicated times.C, PEPCK-Mprotein inductionwasverifiedbyWesternblot inMCF7cells exposed for 24h todifferent concentrationsof thapsigargin (upper
panel) or tunicamycin (lower panel). -Tubulin was used as the loading control. D, MCF7 cells were incubated for the indicated time points in control media
(CT  Veh), in media lacking glutamine, or media containing thapsigargin in the presence or absence of 5 g/ml actinomycin D (ActD). DMSO was used as
vehicle (Veh). E, MCF7 and HCT116 cells were cultured inmedia containing 10M etoposide, 0.4mMH202, 1mM glucose, or media lacking glutamine for 8 h. In
all cases, the -fold induction of PCK2 with respect to control conditions is represented. Data are presented as the mean S.E., n
 3. *, p 0.05; **, p 0.01;
***, p 0.001 relative to basal conditions; one-way ANOVA, with a Newman-Keuls post-hoc test. F, PEPCK-M protein levels were analyzed by Western blot in
MCF7 cells incubated for 16 h in media containing 1 mM glucose.
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provide a selective advantage to growth. Indeed, whereas
PEPCK-C is mainly expressed in the liver, kidney, and adipose
tissue, PEPCK-M is present in a variety of non-gluconeogenic
tissues, including pancreas, brain, leukocytes, heart, or
neurons.
We take the presence of PEPCK-M in most neoplastic cells
and tumors as an indication of a functional role of the enzyme in
the adaptations to cancer cell metabolism. Here we are testing
this hypothesis by deciphering both PCK2 transcriptional reg-
ulation in response to various stimuli including nutrient depri-
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vation and endoplasmic reticulum stress inducers and its func-
tional role in the regulation of cancer cell homeostasis. Our
results identify PEPCK-M as a component of the “amino acid
response” and the “unfolded protein response” and suggest that
PEPCK-M is important to maintain cell progression and sur-
vival, especially under stress conditions.
The study of cancermetabolism, a fundamental part of onco-
genesis, should offer potential therapeutic targets (9, 10).Onco-
FIGURE3.Transcriptional control ofPCK2underaminoacid limitationandERstress ismediatedbyATF4 throughAAREconsensus sequences.A,MCF7
cellswere transiently transfectedwith thePCK2 full-lengthpromoter-luciferase reporter construct (1327 fromthe translational start) and truncatedpromoter
fragments lacking one or both putative amino acid response elements (AARE1 and AARE2). When indicated, cells were glutamine- or serine- and glycine-
deprived (Ser/Gly) or treated with thapsigargin (Thaps; 500 nM) for 16 h. B, MCF7 cells were transiently transfected with the wild type PCK2 full-length
promoter-luciferase reporter constructs or constructs AARE1 and AARE2. When indicated, cells were glutamine- or arginine-deprived (Arg), treated with
thapsigargin (500 nM), or with tunicamycin (Tun; 2M) for 16 h. C, comparison of the PCK2 AARE sequences with functional C/EBP-ATF binding sites present in
other genes.D, alignment of the highly conserved PCK2 AARE1 sequence in different mammals. E, luciferase activity of the wild type, truncated, andmutated
PCK2 promoter constructs co-transfected with an expression plasmid for human ATF4 during 24 h. GFP expression vector was used as control. F, luciferase
activity of the wild type PCK2 promoter construct co-transfectedwith expression plasmids for GFP, ATF4, ATF3, C/EBP, C/EBP, or combinations during 24 h.
InA, B, E, and F luciferase and-galactosidase activitiesweremeasured in cell extracts. -Fold induction of luciferase activity of treated cellswith respect to basal
conditionor control vector is represented.G, PEPCK-Mprotein levelsweremeasuredbyWesternblot afterATF4andATF3cDNA transfection, andGFPwasused
as cDNAcontrol and-tubulin as loading control.H, quantificationof thePEPCK-M levels (normalized to-tubulin) in theexperimentdetailed inG. The average
of three experiments is shown. I, ATF4 and ATF3mRNA levels after transfection were determined by quantitative PCR PEPCK-M levels determined byWestern
blot after C/EBP and C/EBP (J) and C/EBP-LAP and C/EBP-LIP (K) overexpressionwith andwithout thapsigargin treatment (500 nM; 24 h). MCF7 cells were
treated 5 M salubrinal or 500 nM thapsigargin for 24 h (L) and ChIP analysis of ATF4 recruitment to the PCK2 promoter in response to glutamine deprivation
and thapsigargin (500 nM) treatment during 8 h before chromatin preparation for ChIP in MCF7 cells (M). Amplification of input DNA (representing 1% of
immunoprecipitated material) is shown for comparison. N, the level of amplified DNA was quantified by densitometric analysis of three different gels and
corrected for the amount of input DNA. Values are expressed as the -fold change with respect to the control media.O, as the positive control, ChIP analysis of
ATF4 recruitment to the asparagine synthetase (ASNS) AARE sequence in the experiment detailed above is shown. Data are presented as themean S.E., n

3. *, p  0.05; **, p  0.01; ***, p  0.001 relative to basal conditions; #, p  0.05; ##, p  0.01; ###, p  0.001 relative to minimal promoter (A and E),
double-mutated (B) constructs, or GFP overexpression (F). One-way ANOVA, with a Newman-Keuls post-hoc test. CT, control.
FIGURE 4. Induction of PCK2 under amino acid limitation and ER stress depends on GCN2/eIF2/ATF4 and PERK/eIF2/ATF4 axis, respectively. A,
real-time PCR analysis of PCK2 and ATF4mRNA levels in MCF7 cells transfected with ATF4 or control (SCR) siRNA and incubated for 8h in control medium or in
media either lacking glutamine or media supplemented with thapsigargin (Thaps; 500 nM). B, protein levels of PEPCK-M, ATF4, and -tubulin were measured
by immunoblotting in ATF4 siRNA knockdown cells exposed to 500 nM thapsigargin or tomedia lacking serine and glycine for 24 h. C, real-time PCR analysis of
PCK2mRNA levels inMCF7 cells transfectedwithGCN2or control siRNA and incubated for 8 hwith either controlmediumor inmedia lacking either glutamine
or supplementedwith thapsigargin (500nM).CT, control.D,Westernblot analysis of the experimentdetailed inCdemonstratesGCN2knockdownwithblunted
ATF4 induction in response to amino acid depletion but not to ER stress. E, WT and Perk knock-out (Perk/) mouse embryonic fibroblasts were exposed to
glutamine depletion or 500 nM thapsigargin for 8 h, and expression levels of PEPCK-M were quantified by real-time RT-PCR. F, Western blot analysis showing
Perk
/mouse embryonic fibroblasts blunted eif2 phosphorylation and ATF4 induction in response to thapsigargin. In all cases DMSOwas added as vehicle
control. ThemRNA data are shown as -fold change relative to the control condition and represent themeans S.E. of three independent experiments. *, p
0.05; **, p 0.01; ***, p 0.001 relative to basal conditions; ###, p 0.001 relative to same treatment in the other siRNA treatment or genotype. One-way
ANOVA, with a Newman-Keuls post-hoc test.
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genic transformation processes result in a strong demand for
energy to support metabolism and tumor proliferation. Besides
the Warburg effect, by which the tumor cells rely on aerobic
glycolysis (11), a key element of metabolic adaptation in the
tumor is deregulated amino acid requirements. Thus, gluta-
mine is a vital element of tumormetabolism and plays an essen-
tial role in protein synthesis and the supply of ATP and meta-
bolic intermediates for the synthesis of nucleotides and
antioxidant capacity (12). Cell dependence on glutamine,
branded as glutamine addiction by various authors (13–15), is
FIGURE 5. PCK2 knockdown impairs survival under amino acid deprivation and ER stress conditions. PCK2 knockdown decreases glucose consumption
(A) and lactate production (B) inMCF7 andHeLa cells. Glucose/lactate levelsweremeasured in completemedia collected after 8 h of cell culture 48 h after PCK2
knockdown. C, glycolytic flux was assayed bymeasuring the radioactivity of the 3H2O released at the enolase step of glycolysis using [5-
3H]glucose after 1 h of
incubation. D, MTT proliferation assay of MCF7 cells treated with 2 different siRNA against PCK2 for 2 days in complete media. E, FACS analysis of annexin V in
the cells treated as panels A–Ddemonstrates the absence of apoptosis under normal grown conditions. F, MTT proliferation assay ofMCF7 cells expressing two
different shRNAagainst PCK2. PEPCK-Mprotein levelsweredeterminedbyWesternblot.GandH, 48hafter PCK2knockdownwith siRNA,MCF7were incubated
for 24 h in serum-free media either lacking glutamine or supplemented with thapsigargin (Thaps; 500 and 2 M), and protein expression was assayed by
Western blot. Apoptosis is demonstrated by PARP (poly(ADP-ribose) polymerase), caspase-7, and co-chaperone p23 cleavage. Note PEPCK-M efficient knock-
down. I, FACS analysis of annexin V/propidium iodide labeling in Scr (top) and PCK2 siRNA (bottom) of the experiment detailed inG andH (thapsigargin: 2M).
J, quantitation of annexin V labeling depicted in I (three experiments with four replicates per condition). Data are shown as -fold change relative to the control
condition and represent themeans S.E. of3 independent experiments; * p 0.05; **, p 0.01; ***, p 0.001 relative to SCR; ###, p 0.001 relative to the
basal condition. One-way ANOVA, with a Newman-Keuls post-hoc test, or two-tailed Student’s t test (C and E). Annexin V/7-aminoactinomycin D analysis of
MCF7 cells expressing shRNAagainst PCK2either untreated, glutamine-deprived (K andM) or treatedwith thapsigargin (2M) (L andN). The average result and
flow cytometry plots are representative of two experiments.
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reflected in restricted growth and cell death under conditions of
limited or no glutamine. Solid tumors grow at a rate that
exceeds the inflow of substrates through the vasculature and
are frequently exposed to a microenvironment in which the
supply of nutrients and oxygen can be reduced. Increased lactic
acidification, reduced oxygen tension or decreased amino acid
and glucose availability characteristics of this tumor microen-
vironment activate pro-survival signaling pathways, including
theUPR (16–19), which exhibits a robust resemblance with the
amino acid deprivation response (AAR). The inhibition of the
UPR leads to inhibition of tumor progression (19–21). The ISR
interconnects AAR andUPR as they share downstream effector
mechanisms through the phosphorylation of eIF2 and the
activation of ATF4 translation (22). These mechanisms allow
stressed cells to survive by reprogramming gene expression and
metabolic functions, enhancing amino acid uptake, and recy-
cling macromolecules (23, 24).
Here, we demonstrate that ATF4-dependent PCK2 tran-
scription in response to UPR and AAR induction depends on
the eIF2 phosphorylation, mediated by GCN2, activated by
uncharged tRNAduring amino acid limitation, and PERK, acti-
vated by problems with protein processing in the endoplasmic
reticulum, respectively (22, 25). Both kinases, however, could
act as redundant kinases and contribute to PCK2 regulation in
different circumstances according to previous data showing
that eIF2 is indeed phosphorylated in cells lacking PERK or
GCN2 upon UPR and AAR activation, respectively, although
with delayed kinetics in comparison with wild type cells (26,
27). Besides PERK, UPR comprises other two integrated signal-
ing cascades that depend on the ER transmembrane proteins
IRE1 and ATF6 (28, 29).
Thapsigargin and tunicamycin produce concomitant activa-
tion of these three arms. Downstream effectors of IRE1 and
ATF6 (full-length) are XBP1 and cleaved ATF6, respectively.
XBP1 and ATF6 bind cis-acting elements in ER-stress-respon-
sive genes, driving gene expression changes. XBP1 binds to the
unfolded protein response element (UPRE) sequence,
TGACTG(G/A), whereas ATF6 binds to the CCACG portion
of the ER stress response element (ERSE) sequence, CCAAT-
N9-CCACG. For example, PEPCK-C expression in the liver is
down-regulated by ATF6 under ER stress (30, 31). ATF6 down-
regulates PCK1 expression by competing for CREB binding at
the C/EBP binding site with no similarity to PCK2 AARE. Tak-
ing into account that (a) PCK2 proximal promoter does not
contain putative response elements for these transcription fac-
tors and (b) ATF4 silencing produces an almost complete abla-
tion of PEPCK-M induction upon thapsigargin treatment, IRE1
and ATF6 arms do not seem to play a major role per se in PCK2
regulation under these conditions. Also, in addition to PERK
and GCN2, other two eIF2 kinases have been identified in
mammals: PKR (double-strand RNA activated protein kinase,
activated by viral infection) (32) and HRI (heme-regulated
inhibitor kinase) expressed predominantly in erythroid cells
and regulated by heme (33). Because PKR and HRI role remain
poorly defined, we cannot rule out that theymay have a second-
ary role in PCK2 regulation in these or other models, acting as
redundant eIF2 kinases.
We show that ATF4-dependent PCK2 gene activation is nec-
essary for the progress of the ISR response, probably by enhanc-
ing the flexibility of mitochondrial metabolism, providing an
alternative cataplerotic pathway. In the liver and pancreatic
-cell PEPCK-M has been shown to regulate TCA flux and
enhance cataplerosis. Notably, liver-specific PEPCK-Moverex-
pression in mice lacking hepatic PEPCK-C improved defects in
glucose production and TCA cycle flux (4), showing a prefer-
ence for lactate as a substrate. Also, PEPCK-M overexpression
in the presence of PEPCK-C enhanced glucose production, sug-
gesting a role for PEPCK-M in glucose homeostasis both
through its intrinsic gluconeogenic potential and by comple-
menting PEPCK-C, especially in species in which it is highly
expressed, such as in humans. Reinforcing this concept,
PEPCK-M silencing in rat liver severely reduced glucose pro-
duction from lactate and amino acids (34). Another example of
a role of PEPCK-M in cataplerosis is its involvement in the
recycling of citric acid cycle anions in -cells (5), linking
PEPCK-M activity to the recycling of the GTP generated in the
citric acid cycle (by succinyl-CoA synthase) to provide contin-
uous TCA function and enhancing insulin secretion. Notewor-
thy, lactate can be also metabolized in the tumor in these con-
ditions (35) in a reaction that feeds the TCA cycle. Because
PEPCK-Mcataplerotic activity is favored by lactatemetabolism
in hepatocytes, one can envision PEPCK-M to feed forward
phosphoenolpyruvate into the triose-phosphate pool, sub-
strates for serine and glycerol biosynthesis (36). This pathway
could have important consequences for the tumor flexibility
toward nutrient availability.
Two putative ATF4 binding ATF-CRE (AARE) sequences
are present in the PCK2 proximal promoter region. Although,
AARE-1 and AARE-2 are C/EBP-ATF composite sites,
described as sequences that bind heterodimers of ATF and
C/EBP bZIP transcription factors (37, 38), AARE-1 sequence
appears to be the major contributor to the induction of the
PCK2 gene during the AAR and UPR responses. Consistently,
no evidence of ATF4 binding to the AARE-2 site was obtained
by ChIP, although we cannot discard a role of this element in
the activation of PCK2 transcription given that the promoter
constructs retaining theAARE-2 did not exhibit complete abla-
tion of UPR-mediated activation. Furthermore, reporter assays
showed that a shorter construct with no AARE sites starting at
nucleotide 288 5 of exon 1 also demonstrated significant
induction. This sequence contains three GC boxes potential
SP1 and EGR-1 sites that may play an auxiliary role in PCK2
gene regulation. These could help maintain the level of basal
transcription and allow maximal activation of the PCK2 gene
following amino acid or glucose limitation as previously
described for the ASNS gene for sites that show high similarity
to the PCK2 promoter structure (24, 39). However, silencing of
ATF4 in unstressed conditions brought down PCK2 mRNA
content as well, suggesting a direct role of ATF4 in regulating
the basal levels of PCK2 in these cells. The directive role of
ATF4 on PCK2 mRNA levels prompted us to examine the
expression correlation between PCK2 and ATF4 in tumor cell
lines. Both genes are expressed in all cell lines on the NCI-60
data set, a cancer microarray project of 109 human cell lines
from a variety of origins. A non-parametric Spearman correla-
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tion statistics study between ATF4 and PCK2 normalized RNA
counts, allowed us to identify a statistically significant relation-
ship (p 0.0001; r
 0.55). In addition, all cell lines presented in
Table 1 co-expressed ATF4 and PCK2 with significant correla-
tion statistics (p  0.0001; r 
 0.72), pointing to a functional
relationship between both genes in tumors
The most remarkable phenotype observed in unstimulated
PCK2-silenced cells is a decreased glycolytic flux, as measured
by incorporation of [3H]glucose in exponentially growing cells.
This is consistent with lower glucose consumption and lactate
production. Thus, PEPCK-M can represent a regulatory junc-
tion connecting the glycolytic and TCA cycle. However,
because down-regulation by shRNA has an impact on cell pro-
liferation (Fig. 5), it is not clear if the reduction of glycolytic flux
is secondary to reduced growth or a primary event, more so
because reduced PEPCK-M content by siRNA or stable shRNA
knockdown in conditions that elicit AAR or UPR has an impact
on cell survival. The reason for increased mortality is still elu-
sive, although one might argue that the coordinated nutrient-
sensing response requires a dynamic cataplerotic flux from glu-
tamine carbons into phosphoenolpyruvate to enhance the
synthesis of amino acids, such as serine/glycine, together with
othermetabolites required to copewithmetabolic stress. In this
view, serine synthesis also increases TCA cycle flux through the
-ketoglutarate generated in the glutamate-dependent
transamination mediated by phosphoserine aminotransferase
(40, 41). Thus, increasing cataplerosis and GTP recycling, both
intrinsic PEPCK-M roles, could contribute to maximal rate of
serine production.
Interestingly, only PEPCK isozymes can bypass the irrevers-
ible reaction catalyzed by pyruvate kinase and convert TCA
cycle intermediates to glycolytic intermediates. Thus, most
cancer cells must rely on PEPCK-M activity for re-channeling
mitochondrial metabolites upstream of PEP into the glycolytic
pathway (Fig. 6). It is not entirely clear why the mitochondrial
isoform is preferred to its cytosolic counterpart, although
PEPCK-M direct connection with the TCA and its reliance on
phosphoenolpyruvate exportmight proof key to its preferential
utilization. It is important to note that themechanism for phos-
phoenolpyruvate transport across the inner mitochondrial
membrane has not been identified yet. Recent studies also claim
an important role for phosphoenolpyruvate as a phosphate
donor for pyruvate kinase, PKM2, -dependent phosphorylation
of target genes in the cytosol and the nucleus of neoplastic cells,
(42–44). PKM2has a paradoxical low kinase activity, effectively
limiting the lower part of glycolysis, linking glucose and amino
acidsmetabolism Interestingly, PKM2promotes tumorigenesis
(45), whereas its activators or PKM2 overexpression are sup-
pressive (46). Furthermore, pharmacological activators of
PKM2, which reduce carbon flow into the serine biosynthetic
pathway, produce a profound dependence on the nonessential
amino acid serine for continued cell proliferation. This causes a
strong up-regulation of multiple enzymes involved in amino
acid metabolic pathways, including PEPCK-M (47). In this
sense, it is interesting to view this pathway in coordinationwith
other enzymes, such as Tigar or PFKFB4, that control the flow
to the lower glycolytic pathway to account for increased diver-
sion of sugar carbons into the pentose-phosphate pathway
(Fig. 6).
Glucose reduction activates ER stress and up-regulates
ATF4, and as demonstrated in the present work, it correspond-
ingly regulates PCK2 mRNA. Our data provide a mechanistic
explanation for results by Leithner et al. (48) showing increased
PCK2 expression and activity under low glucose in lung cancer
cell lines. Phosphoenolpyruvate enrichment from [13C3]lactate
was dependent on PEPCK-M presence under these conditions.
Also, Park et al. (49) has recently proposed PEPCK-M as a
potential predictor of chemoradiation response, as its expres-
sion correlates with sensitivity to 5-fluouracyl. Consistent with
our data, both studies noted decreased proliferation after PCK2
knockdown.
Overall, we demonstrate that PEPCK-M is a pro-survival,
metabolic stress target gene with potential significance to our
understanding of cancer cell metabolism. Its precise contribu-
FIGURE 6. A, schematic diagram of our working hypothesis. Both GCN2 and PERK activation by stress lead to the phosphorylation of eif2, which in turn
increases the translation of ATF4. ATF4 binds to the AARE sequences in the PCK2 gene promoter, enhancing its transcriptional activity. B, schematic diagram
of PEPCK-M involvement in cataplerosis and TCA cycle metabolism. PK, pyruvate kinase; PC, pyruvate carboxylase;ME1, malic enzyme 1.
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tion to stress adaptations needs further examination by meta-
bolic flux analysis. This pathway provides a novel window for
therapeutic intervention in cancer.
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